Skip to main content
. 2021 Dec 31;2021:4952447. doi: 10.1155/2021/4952447

Figure 1.

Figure 1

Ranolazine effect on Hb1Ac and short-term GV. (a) Patients with Hb1Ac < 7% at baseline and 3 months in the two groups; (b) Patients with TIR > 70% at baseline and 3 months in the two groups. Hb1Ac: haemoglobin 1Ac; TIR: time in range.